In its first earnings report since passing the anniversary of its international respiratory device recall, Philips saw yet another quarter of slipping sales.
For the second quarter of 2022, the medtech giant reported 4.2 billion euros ($4.3 billion) in sales, a drop of about 7% compared to the same period last year.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,